New doc set available in Mark2Cure

A lot has happened since our last Mark2Cure blog post. Andrew and other members of the Mark2Cure team were on twitter on Feb. 24th to talk about Mark2Cure during the citscichat focused on language-based citizen science projects. A storify of the event can be found here if you’re curious as to what was discussed. Two days later, our team attended in the NGLY1/CDG conference (that was mentioned in...
read more

Author page for Mark2Cure’s first paper now LIVE!

The authors page acknowledging the contributors to the Mark2Cure’s first paper is now LIVE! Please note that only users who submitted annotations or contributed feedback during the beta phase will be listed on this site. If you have been following our journey since that time, but did not contribute during this phase, thank you for your support!  Please contribute annotations and feedback...
read more

Crowdsourcing for information extraction and for peer review

If it hasn’t been evident enough from the Gene Wiki activity, or BioGPS’s community expandable resources (plugins), or our citizen science initiative, Mark2Cure, we’re very enthusiastic about crowdsourcing and community-based resources here in the Su Lab. If you’ve been following Mark2Cure, you may know that our beta experiment focused on named entity recognition for...
read more

New Mark2Cure features in development

Over the last week, we’ve been user-testing some features which we hope to introduce in the future. Some of these features are still in very early stages of development, so it may be awhile before our Mark2Curators start to see them. Since some of our Mark2Curators are also members of other rare disease or patient communities, we’d like to reiterate how Mark2curators could leverage their...
read more

How helping find clues for NGLY1-deficiency can help other rare disease communities

When we first started moving Mark2Cure from Amazon Mechanical Turk to the internet at large, we decided early on that we would let the contributors take the steering wheel on the project. During beta testing, advocates from various rare disease communities (like Hashimoto’s Encephalitis, Cystic Fibrosis, and Cystinosis) made significant contributions; but the NGLY1 community made a concerted...
read more

Making a Mark– Mighty enthusiasm for what Mark2Curators have done

As promised in last week’s blog post, we’d like to share some of the feedback we received from our update meeting with Dr. Hudson Freeze, the Mights, and Karen Ho (NGLY1.org’s Chief Scientific Officer.)  The Mark2cure development team started the meeting with a summary of what the Mark2Cure community has accomplished and its future directions (see blog post for details). Because our...
read more